ARCHIVES

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Guest Editorial: Nobel Laureates Offer Simple Formula To Save CPRIT From “Infamy and Irrelevance”

October 19, 2012

CMS Advisors Express Low Confidence In Low-Dose CT Screening for Lung Cancer

May 9, 2014

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

Brain Tumor Research Needs Stronger Interdisciplinary Collaboration, PRG Says.

November 17, 2000

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002